2000

• Albert D, Aksentijevich S, Hurst S, Fries J, Wolfe F. Modeling Therapeutic Strategies in Rheumatoid Arthritis: Use of Decision Analysis and Markov Models. J Rheum. 2000;27(3):644-652.
• Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343(22):1586-93.
• Evans CH, Ghivizzani SC, Herndon JH, Wasko MC, Reinecke J, Wehling P, et al. Clinical trials in the gene therapy of arthritis. Clin Orthop 2000(379 Suppl):S300-7.
• Falkner D, Wilson J, Fertig N, Clawson K, Medsger TA, Jr., Morel PA. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). J Rheumatol 2000;27(5):1196-202.
• Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133(8):635-46.
• Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med 2000;133(9):726-37.
• Fries J. Compression of Morbidity in the Elderly. Vaccine. 2000;18(16):1584-1589.
• Fries J. Current Treatment Paradigms in Rheumatoid Arthritis. Rheumatology. 2000;39(Suppl 1):30-35.
• Garcia-Garcia J, Gonzalez-Pascual E, Pou-Fernandez J, Singh G, Jimenez R. Development of a Spanish (Castillian) version of the Childhood Health Assessment Questionnaire. Measurement of health status in children with juvenile chronic arthritis. Clin Exp Rheumatol. 2000;18(1):95-102.
• Kuwana M, Medsger TA, Jr., Wright TM. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J Immunol 2000;164(12):6138-46.
• Lipani J, Strand V, Woodworth T, et al. A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis. J Rheumatol. 2000;27(4):827-30.
• Lubeck D, Hubert H, Fries J. Properties of the Health Assessment Questionnaire, CES-D and Modified MOS Scales in a community population of seniors. Quality of Life Research. 2000;9(3):327.
• Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000;59(5):321-5.
• Ortendahl M, Schettler JD, Fries JF. Factors influencing length of time taking methotrexate in rheumatoid arthritis. J Rheumatol. 2000;27(5):1139-47.
• Poormoghim H, Lucas M, Fertig N, Medsger TA, Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 2000;43(2):444-51.
• Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs - a view from the ARAMIS database. Am J Therapeutics. 2000;7(2):115-122.
• Steen VD, Medsger TA, Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000;133(8):600-3.
• Steen VD, Medsger TA, Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43(11):2437-44.
• Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum. 2000;43(2):378-85.
• Wong J, Ramey D, Singh G. The morbidity, mortality and economics of rheumatoid arthritis. Selected for presentation at the Economics Mini-symposium of the 64th Annual Scientific Meeting of the American College of Rheumatology. Arthritis Rheum. 2000;43((Suppl)):S389.

ARAMIS |  Investigators |  Research |  Publications |  HAQ |  Pharmaceutical Collaborations

©2001 Stanford University. All Rights Reserved. If you experience any difficulty with this site, please email our webmaster. Last updated October 2001.